Mouse Pulmonary Dose- and Time Course-Responses Induced by Exposure to Nitrogen-Doped Multi-Walled Carbon Nanotubes
Public Domain
-
2020/01/01
-
Details
-
Personal Author:Andrew M ; Battelli L ; Castranova, Vincent ; Chen BT ; Hamilton RF Jr. ; Holian A ; Orandle M ; Porter DW ; Terrones M ; Tsuruoka S ; Wolfarth MG ; Wu N ; Zheng P
-
Description:Objective: In this study, we compared in vitro and in vivo bioactivity of nitrogen-doped multi-walled carbon nanotubes (NDMWCNT) to MWCNT to test the hypothesis that nitrogen doping would alter bioactivity. Materials and Methods: High-resolution transmission electron microscopy (TEM) confirmed the multilayer structure of MWCNT with an average layer distance of 0.36 nm, which was not altered by nitrogen doping: the nanomaterials had similar widths and lengths. In vitro studies with THP-1 cells and alveolar macrophages from C57BL/6 mice demonstrated that NDMWCNT were less cytotoxic and stimulated less IL-1beta release compared to MWCNT. For in vivo studies, male C57BL/6J mice received a single dose of dispersion medium (DM), 2.5, 10 or 40 ug/mouse of NDMWCNT, or 40 ug/mouse of MWCNT by oropharyngeal aspiration. Animals were euthanized between 1 and 7 days post-exposure for whole lung lavage (WLL) studies. Results and Discussion: NDMWCNT caused time- and dose-dependent pulmonary inflammation. However, it was less than that caused by MWCNT. Activation of the NLRP3 inflammasome was assessed in particle-exposed mice by determining cytokine production in WLL fluid at 1 day post-exposure. Compared to DM-exposed mice, IL-1beta and IL-18 were significantly increased in MWCNT- and NDMWCNT-exposed mice, but the increase caused by NDMWCNT was less than MWCNT. At 56 days post-exposure, histopathology determined lung fibrosis in MWCNT-exposed mice was greater than NDMWCNT-exposed mice. Conclusions: These data indicate nitrogen doping of MWCNT decreases their bioactivity, as reflected with lower in vitro and in vivo toxicity inflammation and lung disease. The lower activation of the NLRP3 inflammasome may be responsible. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0895-8378
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:24-38
-
Volume:32
-
Issue:1
-
NIOSHTIC Number:nn:20058754
-
Citation:Inhal Toxicol 2020 Jan; 32(1):24-38
-
Contact Point Address:Dale W. Porter, Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, M/S 2015, Morgantown, WV 26505, USA
-
Email:DPorter@cdc.gov
-
CAS Registry Number:
-
Federal Fiscal Year:2020
-
Peer Reviewed:True
-
Source Full Name:Inhalation Toxicology
-
Collection(s):
-
Main Document Checksum:urn:sha-512:6d027b4ea2b942f2fe7ad503e897a28adb410246fdab1831adf04e9a2edf1b3d7c4342ebaf6f1681941671dbcc1f2c71ac6ce0352012702be6e543f79177852b
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like